Overview / Abstract: |
Target Audience This activity is designed to meet the educational needs of pulmonologists, infectious disease specialists, primary care providers, and other health care providers who may be involved in the management of patients with COVID-19. Program Overview Providers managing patients with COVID-19 are not knowledgeable about the latest evidence-based monoclonal antibody treatments available. Methods for delivering these treatments are also discussed. Learning Objectives Upon completion of this activity, participants should be better able to: Review the utility of administering monoclonal antibodies for the management of at-risk patients with COVID-19, including variants |
Expiration |
Nov 30, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty FACULTY_NAME FACULTY_NAME |
Sponsors / Supporters / Grant Providers |
GlaxoSmithKline |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Monoclonal Antibodies Free CE CME |